They found that transformation occurs through distinct trajectories characterized by genomic profiles and clonal evolution: monocytic (Mo-AML, 53%), immature myeloid (My-AML, 43%), or erythroid AML (Ery-AML, 2%), which were defined by complex karyotypes and TP53 mutations. This evidence concerns the gene TP53 and acute myeloid leukemia.